Back
Novonesis (Novozymes A/S) 10K Form
Buy
71
NVZMY
Novonesis (Novozymes A/S)
Last Price:
$59.77
Seasonality Move:
6.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVZMY News And Ratings
See the #1 stock for the next 7 days that we like better than NVZMY
NVZMY Financial Statistics
Sales & Book Value
| Annual Sales: | $4.7B |
|---|---|
| Cash Flow: | $118.9M |
| Price / Cash Flow: | 32.89 |
| Annual Sales: | $27.36 |
| Price / Book: | 2.47 |
Profitability
| EPS (TTM): | 1.40030 |
|---|---|
| Net Income (TTM): | $655M |
| Gross Margin: | $2.2B |
| Return on Equity: | 5.31% |
| Return on Assets: | 3.56% |
Novonesis (Novozymes A/S) Earnings Forecast
Key Novonesis (Novozymes A/S) Financial Ratios
-
The Gross Profit Margin over the past 27 years for NVZMY is 47.85%.
-
The Selling, General & Administrative Expenses for NVZMY have been equal to 21.93% of Gross Profit Margin.
-
The Research & Development expenses have been 8.56% of Revenue.
-
The Interest Expense is 13.81% of Operating Income.
-
The Net Earning history of NVZMY is 14.04% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 21 years.
Novonesis (Novozymes A/S) Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | NVZMY |
| Website: | novonesis.com |
Debt
| Debt-to-Equity Ratio: | 0.28 |
|---|---|
| Current Ratio: | 0.72 |
| Quick Ratio: | 0.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 42.43 |
|---|---|
| Forward P/E Ratio: | 0 |
NVZMY Technical Analysis vs Fundamental Analysis
Buy
71
Novonesis (Novozymes A/S) (NVZMY)
is a Buy
Is Novonesis (Novozymes A/S) a Buy or a Sell?
-
Novonesis (Novozymes A/S) stock is rated a BuyThe current Novonesis (Novozymes A/S) [NVZMY] share price is $59.77. The Score for NVZMY is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.